A new trading day began on Friday, with Emergent Biosolutions Inc (NYSE: EBS) stock price up 10.57% from the previous day of trading, before settling in for the closing price of $9.08. EBS’s price has ranged from $4.02 to $13.41 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 836.96%. With a float of $50.44 million, this company’s outstanding shares have now reached $52.70 million.
Emergent Biosolutions Inc (EBS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Emergent Biosolutions Inc is 3.95%, while institutional ownership is 79.63%. The most recent insider transaction that took place on Nov 10 ’25, was worth 187,623. In this transaction Director of this company sold 17,801 shares at a rate of $10.54, taking the stock ownership to the 119,858 shares. Before that another transaction happened on Nov 07 ’25, when Company’s Director sold 8,552 for $10.00, making the entire transaction worth $85,520. This insider now owns 88,980 shares in total.
Emergent Biosolutions Inc (EBS) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.05 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.97 per share during the current fiscal year.
Emergent Biosolutions Inc (NYSE: EBS) Trading Performance Indicators
Here are Emergent Biosolutions Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.67. Likewise, its price to free cash flow for the trailing twelve months is 376.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.29, a number that is poised to hit 0.38 in the next quarter and is forecasted to reach -0.45 in one year’s time.
Technical Analysis of Emergent Biosolutions Inc (EBS)
Let’s dig in a bit further. During the last 5-days, its volume was 0.88 million. That was inferior than the volume of 1.21 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 21.71%.
During the past 100 days, Emergent Biosolutions Inc’s (EBS) raw stochastic average was set at 56.77%, which indicates a significant increase from 50.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.56 in the past 14 days, which was higher than the 0.51 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.55, while its 200-day Moving Average is $7.38. However, in the short run, Emergent Biosolutions Inc’s stock first resistance to watch stands at $10.47. Second resistance stands at $10.89. The third major resistance level sits at $11.62. If the price goes on to break the first support level at $9.32, it is likely to go to the next support level at $8.59. The third support level lies at $8.17 if the price breaches the second support level.
Emergent Biosolutions Inc (NYSE: EBS) Key Stats
With a market capitalization of 527.30 million, the company has a total of 52,520K Shares Outstanding. Currently, annual sales are 1,044 M while annual income is -190,600 K. The company’s previous quarter sales were 231,100 K while its latest quarter income was 51,200 K.
